Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
5.74
+0.11 (1.95%)
Jul 9, 2026, 3:28 PM EDT - Market open
Rockwell Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5.4 | -5.31 | -0.48 | -8.44 | -18.68 | -32.67 |
Depreciation & Amortization | 4.3 | 4.33 | 4.14 | 3.45 | 2.59 | 2.52 |
Stock-Based Compensation | 1.85 | 1.82 | 1.29 | 0.93 | 0.32 | 0.94 |
Other Adjustments | -0.31 | 0.12 | 0.78 | 1.89 | 0.97 | 0.53 |
Change in Receivables | 0.66 | -0.1 | 2.61 | -4.64 | -0.35 | -1.74 |
Changes in Inventories | 1.51 | 2.78 | -0.33 | 1.18 | -2.1 | -0.66 |
Changes in Accounts Payable | 1.05 | -0.87 | -1.65 | 0.46 | 0.31 | -0.42 |
Changes in Accrued Expenses | -1.48 | -1.68 | -1.03 | -0.38 | 2.53 | -0.05 |
Changes in Unearned Revenue | -0.24 | -0.48 | -0.05 | -3.81 | -3.83 | -2.03 |
Changes in Other Operating Activities | -1.14 | -2.88 | -2.61 | -7.3 | -0.83 | -4.79 |
Operating Cash Flow | 2.66 | -0.66 | 4.2 | -9.41 | -16.93 | -33.53 |
Operating Cash Flow Growth | -14.02% | - | - | - | - | - |
Capital Expenditures | -0.9 | -0.54 | -1.01 | -0.28 | -0.28 | -0.52 |
Sale of Property, Plant & Equipment | 0.18 | - | - | - | - | - |
Purchases of Investments | -28.34 | -24.2 | -5.86 | -5.7 | -21.3 | -26.06 |
Proceeds from Sale of Investments | 20.4 | 16.2 | 2 | 15.3 | 19.18 | 26.89 |
Payments for Business Acquisitions | - | - | - | -12.36 | - | - |
Investing Cash Flow | -8.67 | -8.54 | -4.87 | -3.05 | -2.4 | 0.31 |
Short-Term Debt Repaid | -0.66 | -0.66 | -0.65 | -0.99 | -1.44 | -1.53 |
Net Short-Term Debt Issued (Repaid) | -0.66 | -0.66 | -0.65 | -0.99 | -1.44 | -1.53 |
Long-Term Debt Repaid | - | - | - | -2 | -11.75 | -0.75 |
Net Long-Term Debt Issued (Repaid) | - | - | - | -2 | -11.75 | -0.75 |
Issuance of Common Stock | - | 7.82 | 10.18 | 14.86 | 14.91 | 0.11 |
Repurchase of Common Stock | - | - | - | - | - | -0.01 |
Net Common Stock Issued (Repurchased) | - | 7.82 | 10.18 | 14.86 | 14.91 | 0.1 |
Issuance of Preferred Stock | - | - | - | - | 14.92 | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | 14.92 | - |
Other Financing Activities | -2.93 | -2.9 | -2.19 | -0.52 | -0.48 | - |
Financing Cash Flow | 4.22 | 4.25 | 7.35 | 11.34 | 16.15 | -2.18 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | -0.01 | -0 | -0 | - |
Net Cash Flow | -1.78 | -4.95 | 6.68 | -1.12 | -3.18 | -35.4 |
Free Cash Flow | 1.76 | -1.2 | 3.19 | -9.7 | -17.21 | -34.06 |
FCF Margin | 2.60% | -1.73% | 3.14% | -11.60% | -23.64% | -54.99% |
Free Cash Flow Per Share | 0.47 | -0.33 | 1.03 | -4.16 | -12.03 | -39.94 |
Levered Free Cash Flow | -2.97 | -5.32 | -3.66 | -18.11 | -33.47 | -40.91 |
Unlevered Free Cash Flow | -1.72 | -4.03 | -1.93 | -13.35 | -18.38 | -36.29 |